Showing results (161-170 of 491) with videos related to
Sort By:
Pageof 50
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Induction of Diabetes Abolishes the Antithrombotic Effect of Clopidogrel in Apolipoprotein E-Deficient MiceA Sugidachi, K Ohno, J A Jakubowski, et al.Physics in Medicine and Biology|January 12, 2011
Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibodyJ Schwartz, J S Jaggi, J A O'Donoghue, et al.Journal of Vascular Surgery|February 1, 1986
The natural history of endothelial structure and function in arterialized vein graftsH L Bush, J A Jakubowski, G R Curl, et al.Clinical Pharmacokinetics|June 5, 2017
Population Pharmacokinetic and Exposure-Response Analyses of Prasugrel in Pediatric Patients with Sickle Cell AnemiaBrian A Moser, Elizabeth S LaBell, Emmanuel Chigutsa, et al.Blood|June 1, 1984
Platelet size and age determine platelet function independentlyC B Thompson, J A Jakubowski, P G Quinn, et al.Thrombosis and Haemostasis|May 1, 2010
Relationship between degree of P2Y12 receptor blockade and inhibition of P2Y12-mediated platelet functionHeather M Judge, Robert J Buckland, Atsuhiro Sugidachi, et al.Journal of Clinical Laboratory Analysis|July 22, 1998
Quantitative detection of platelet GPIIb-IIIa receptor antagonist activity using a flow cytometric methodL J Green, P Marder, S L Um, et al.Journal of Thrombosis and Haemostasis : JTH|January 17, 2017
Incomplete reversibility of platelet inhibition following prolonged exposure to ticagrelorA J Gerrits, J A Jakubowski, A Sugidachi, et al.Platelets|February 26, 2008
The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory platelet responsesHeather M Judge, Robert J Buckland, Atsuhiro Sugidachi, et al.The Biochemical Journal|November 14, 1997
Human group II 14 kDa phospholipase A2 activates human plateletsJ Polgár, R M Kramer, S L Um, et al.Pageof 50